RESULTS FOR : 'Antibodies'
Showing 1 to 5 of 5 results |    
Keyword Search
Show#
Show#
Results Category/Section
Analytical Biophysical Tools To Accelerate Discovery of Therapeutic Antibodies

The innate ability of antibodies to bind their targets with high affinity and exquisite specificity is leveraged in the discovery of therapeutic antibodies to treat a broad range of diseases including cancer, autoimmune disease and heart disease.

Therapeutic Antibodies - New tools to enhance the antibody drug pipeline

Therapeutic antibodies are the fastest growing class of drugs, with continuous increases in the number of innovator and biosimilar drugs in development.

Evolving strategies for application-specific validation of research use antibodies

Antibodies have become a vital tool among researchers in the life sciences and are routinely being used in a number of diverse immunoassay applications, including Western blotting (WB), immunoprecipitation (IP), flow cytometry, enzyme-linked immunosorbent assays (ELISA), quantitative immunofluorescence (QIF) and immunohistochemistry (IHC).

Monoclonal Antibodies - Magic bullets or a shot in the dark

It has been 16 years since the first monoclonal antibody was approved for therapy in acute transplant rejection. Now, with a further nine therapeutic monoclonal antibodies approved for use and some 16 in phase III trials or beyond, are we still grappling with the same old issues or are magic bullets finally hitting the mark?

New Ways to Optimise Therapeutic and Diagnostic Antibodies

Monoclonal antibodies are the fastest-growing category of research within the biotech and pharmaceutical industries. Several monoclonal antibodies are listed in the top 10 selling blockbusters, and the market forecast predicts that the number of monoclonal antibodies within the top 10 will further increase (1).